FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2015/02/005528 [Registered on: 11/02/2015] Trial Registered Retrospectively
Last Modified On: 03/12/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Single Arm Study 
Public Title of Study   To evaluate the Safety and efficacy of Unani formulation in the treatment of Dyspepsia 
Scientific Title of Study   Clinical Validation of Unani Pharmacopoeial Formulations Jawarish e Kamooni and Arq e Badiyan in Sū’ al-Hadm (Dyspepsia)  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
SH/D/JKAB CLNVAL/CCRUM 13-14   Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  PROF S SHAKIR JAMIL 
Designation  DIRECTOR GENERAL 
Affiliation  Central Council for Research in Unani Medicine (CCRUM), 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

West
DELHI
110058
India 
Phone  01128521981  
Fax  01128522965  
Email  unanimedicine@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR K M SIDDIQUI 
Designation  DEPUTY DIRECTOR 
Affiliation  Central Council for Research in Unani Medicine (CCRUM), 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

West
DELHI
110058
India 
Phone  9810161758  
Fax  01128522965  
Email  ccrum507@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR PRADEEP KUMAR  
Designation  RESEARCH OFFICER SCIENTIST III 
Affiliation  Central Council for Research in Unani Medicine (CCRUM), 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

West
DELHI
110058
India 
Phone  01128521981  
Fax  01128522965  
Email  drpradeepkumar2001@gmail.com  
 
Source of Monetary or Material Support  
Infrastructural support: 1.Central Research Institute of Unani Medicine (CRIUM), Lucknow 2.Regional Research Institute of Unani Medicine (RRIUM), Patna 3.Regional Research Institute of Unani Medicine (RRIUM), Kolkata 4.Clinical Research Unit (CRU), Meerut 5.Clinical Research Unit (CRU), Kurnool Monetary Support : Central Council for Research in Unani Medicine (CCRUM), New Delhi  
 
Primary Sponsor  
Name  Central Council for Research in Unani Medicine CCRUM New Delhi  
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058.  
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 5  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR ZIAUL HAQUE SIDDIQUI  CENTRAL RESEARCH INSTITUTE, LUCKNOW  C 39 TEHRI PULIA, PO SECTOR C JANKIPURAM
Lucknow
UTTAR PRADESH 
05222732088

crium_lko@yahoo.co.in 
DR JAWADUL HAQ  Clinical Research Unit (CRU), Kurnool  DR ABDUL HAQ UNANI MEDICAL COLLEGE, 40/23 PARK ROAD
Kurnool
ANDHRA PRADESH 
09502443555

cru.kurnool@gmail.com 
DR MOHD TARIQ KHAN  Clinical Research Unit (CRU), Meerut  Gulzar-e- Ibrahim, Gali No. 2, Tanki Wali Gali, Bhomiya Ka Pul, lesari Road
Meerut
UTTAR PRADESH 
9012843253

doctormtk@gmail.com 
DR MOHAMMAD NAWAB  Regional Research Institute of Unani Medicine (RRIUM), Kolkata  79, CHITRANJAN AVENUE, KOLKATA
Kolkata
WEST BENGAL 
03322372107
03322372107
drnawab20022000@gmail.com 
DR MOHAMMAD ISHTIYAQ ALAM  Regional Research Institute of Unani Medicine (RRIUM), Patna  Manas Path opp. Patna City Hospital
Patna
BIHAR 
06122631106

rriumpatna@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 5  
Name of Committee  Approval Status 
Clinical Research Unit (CRU), Kurnool   Approved 
Clinical Research Unit (CRU), Meerut   Approved 
Regional Research Institute of Unani Medicine (RRIUM), Kolkata   Approved 
CENTRAL RESEARCH INSTITUTE, LUCKNOW  Approved 
Regional Research Institute of Unani Medicine (RRIUM), Patna  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K30||Functional dyspepsia, Sū’ al-Hadm (Dyspepsia),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1. Jawarish e Kamooni 2.Arq e Badiyan  1.Jawarish e Kamooni ,Orally,5 gm Twice daily, with water after meals 2.Arq e Badiyan Orally,60 Twice daily with water after meals Duration of treatment 2 weeks  
Comparator Agent  nil  na 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1. Patients of either sex in the age group of 18-55 years.
2. Patients having abdominal discomfort with any of the following symptoms of Sū’ al-Hadm (Dyspepsia) due to Sū’-i-Mizāj Bārid:
• Abdominal pain
• Heartburn
• Acid Regurgitation
• Eructation
• Nausea and Vomiting
• Abdominal Distention
 
 
ExclusionCriteria 
Details  • Dysphagia
• Inflammatory Bowel Disease e.g. Ulcerative colitis, Crohn’s Disease
• Palpable abdominal mass
• History of Zollinger ellison syndrome
• History of sudden weight loss
• History of long-term medication
• Known cases of cancer, anaemia/ haematemesis/ melaena
• Known cases of severe hepatic, renal or cardiac ailments
• Diabetes Mellitus
• H/o addiction (tobacco chewing, smoking, alcohol, drugs)
• Pregnancy and lactation
 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Improvement in signs and symptoms of Sū’ al-Hadm (Dyspepsia)   2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Haematological and biochemical assessment for safety assessment   2 weeks 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/02/2014 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This study is designed as a multicentric open trial in patients with Sū’ al-Hadm (Dyspepsia). After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients will be assessed clinically every week. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be two weeks. . Laboratory parameters for safety assessment will be conducted at baseline and end of study.  

Composition of Jawarish e Kamooni

S. No.

Unani Name

Scientific Name

Weight

1.

Zeera Siyah Mudabbar

Cuminum cyminum

350 g

2.

Barg-e-Sudab

Ruta graveolens

350 g

3.

Filfil Siyah

Piper nigrum

350 g

4.

Zanjabeel

Zingiber officinale

350 g

5.

Boora-e-Armani

Borax

100 g

6.

A‘sal or Qand Safaid

Honey or Sugar

5 kg


Composition of Arq-e- Badiyan

S. No.

Unani Name

Scientific Name

Weight

1.

Badiyan

Foeniculum vulgare

01 Part

2.

Aab

Oxidane (Water)

20 Parts


 
Close